1,237 results on '"O'Connor, Christopher"'
Search Results
2. Novel Initiative Increasing GDMT Use among Patients with Heart Failure with Reduced Ejection Fraction
3. Evaluation of the hemocompatibility of the Direct Oral Anti-Coagulant apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study
4. Iterative Bragg peak removal on X-ray absorption spectra with automatic intensity correction
5. Utilizing Quality of Life Adjusted Days Alive and Out of Hospital in Heart Failure Clinical Trials
6. ‘Resources and energy development’: An International Society for the Study of Rural Crime Roundtable
7. Interrogating site dependent kinetics over SiO2-supported Pt nanoparticles
8. Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping
9. Use of win time for ordered composite endpoints in clinical trials
10. In Situ Analysis of Gas Dependent Redistribution Kinetics in Bimetallic Au-Pd Nanoparticles
11. Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction
12. Emerging Researchers in Exoplanetary Science (ERES): Lessons Learned in Conference Organization for Early-Career Researchers
13. Variation Of Prespecified Subgroups In Large-Scale HF Outcome Trials
14. Bridging the Gap Between Effective Therapies and Optimal Clinical Outcomes
15. Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies
16. Impact of vasodilators on diuretic response in patients with congestive heart failure: a mechanistic trial of cimlanod (BMS‐986231)
17. Design and Rationale for the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study
18. Relationship of Race With Functional and Clinical Outcomes With the REHAB‐HF Multidomain Physical Rehabilitation Intervention for Older Patients With Acute Heart Failure
19. Spatial Heterogeneity of Glomerular Phenotypes Impacts Kidney Biopsy Findings
20. Elucidating the water–anatase TiO2(101) interface structure using infrared signatures and molecular dynamics
21. Interrogating Site Dependent Kinetics over SiO2-Supported Pt Nanoparticles
22. Curation of Heart Failure Shock With Pulmonary Artery Catheters
23. Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial
24. On the pollution of white dwarfs by exo-Oort cloud comets
25. Inhibiting NLRP3 signaling in aging podocytes improves their life- and health-span
26. Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure
27. Giant Planet Engulfment by Evolved Giant Stars: Light Curves, Asteroseismology, and Survivability
28. Loxodromes in open multisection lasers
29. Estimating WUI exposure probability to a nearby wildfire
30. Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA
31. Prognostic Value Of Composite Biomarkers In ASCEND-HF Biomarker Registry
32. Relationship Of Race With Outcomes Following A Novel Physical Rehabilitation Intervention In Older Patients Hospitalized For Heart Failure: Insights From REHAB-HF.
33. Patients With Type 2 Diabetes Are More Resistant To Diuresis And Have Worse Acute Heart Failure Outcomes: Findings From ASCEND-HF
34. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure
35. Advanced Practice Provider Urgent Outpatient Clinic for Patients With Decompensated Heart Failure
36. Sex-Related Differences in Patient Characteristics, Hemodynamics, and Outcomes of Cardiogenic Shock: INOVA-SHOCK Registry
37. A Quantitative Analysis of Fuel Break Effectiveness Drivers in Southern California National Forests
38. The Role of Surface Hydroxyls in the Mobility of Carboxylates on Surfaces: Dynamics of Acetate on Anatase TiO2(101)
39. WHAT IS THE VALUE OF REPEATED NT-PROBNP MEASUREMENTS IN CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION?
40. SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes
41. TOP U.S. CARDIOLOGY AND HEART SURGERY HOSPITALS ARE UNDER-PERFORMING IN MEASURES OF PATIENT EXPERIENCE
42. NT-PROBNP DURING SCREENING IN THE STUDY OF VERICIGUAT IN PARTICIPANTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (VICTORIA) TRIAL: INSIGHTS INTO OUTCOMES AND VERICIGUAT
43. UTILIZATION OF GUIDELINE DIRECTED MEDICAL THERAPY FOR HEART FAILURE IN CARDIOGENIC SHOCK SURVIVORS: AN INOVA SHOCK REGISTRY ANALYSIS
44. Achieving Ultra-High Selectivity to Hydrogen Production from Formic Acid on Pd–Ag Alloys
45. Impact of COVID-19 on Heart Failure Clinical Trials
46. A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study
47. The Role of Surface Hydroxyls in the Mobility of Carboxylates on Surfaces: Dynamics of Acetate on Anatase TiO2(101)
48. Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy
49. Indigenous fire management and cross-scale fire-climate relationships in the Southwest United States from 1500 to 1900 CE
50. Clinical Predictors of Adherence to Exercise Training Among Individuals With Heart Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.